JPMorgan Chase & Co’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.17M Sell
342,006
-310,470
-48% -$7.42M ﹤0.01% 2360
2025
Q1
$16.2M Sell
652,476
-103,700
-14% -$2.58M ﹤0.01% 1824
2024
Q4
$14.2M Buy
756,176
+20,202
+3% +$381K ﹤0.01% 1991
2024
Q3
$11.1M Buy
735,974
+135,363
+23% +$2.04M ﹤0.01% 2092
2024
Q2
$17.2M Buy
600,611
+515,539
+606% +$14.7M ﹤0.01% 1746
2024
Q1
$2.49M Sell
85,072
-55,578
-40% -$1.62M ﹤0.01% 3019
2023
Q4
$4.75M Buy
140,650
+49,812
+55% +$1.68M ﹤0.01% 2600
2023
Q3
$2.79M Sell
90,838
-38,592
-30% -$1.18M ﹤0.01% 2794
2023
Q2
$5.19M Buy
129,430
+45,533
+54% +$1.82M ﹤0.01% 2465
2023
Q1
$3.42M Buy
83,897
+4,253
+5% +$174K ﹤0.01% 2693
2022
Q4
$3.07M Buy
79,644
+204
+0.3% +$7.87K ﹤0.01% 2693
2022
Q3
$4.23M Buy
79,440
+9,034
+13% +$481K ﹤0.01% 2447
2022
Q2
$4.1M Buy
70,406
+9,518
+16% +$555K ﹤0.01% 2536
2022
Q1
$4.65M Buy
60,888
+9,350
+18% +$714K ﹤0.01% 2619
2021
Q4
$3.1M Buy
51,538
+570
+1% +$34.3K ﹤0.01% 2911
2021
Q3
$2.86M Sell
50,968
-1,963
-4% -$110K ﹤0.01% 2942
2021
Q2
$3.21M Sell
52,931
-587
-1% -$35.6K ﹤0.01% 2922
2021
Q1
$3.75M Buy
53,518
+8,803
+20% +$617K ﹤0.01% 2839
2020
Q4
$2.68M Sell
44,715
-6,857
-13% -$410K ﹤0.01% 2790
2020
Q3
$3.06M Buy
51,572
+30,649
+146% +$1.82M ﹤0.01% 2521
2020
Q2
$1.1M Sell
20,923
-3,720
-15% -$195K ﹤0.01% 2961
2020
Q1
$826K Sell
24,643
-913
-4% -$30.6K ﹤0.01% 3053
2019
Q4
$1.16M Buy
25,556
+2,606
+11% +$118K ﹤0.01% 2981
2019
Q3
$874K Sell
22,950
-135,063
-85% -$5.14M ﹤0.01% 3124
2019
Q2
$6.94M Buy
158,013
+144,108
+1,036% +$6.33M ﹤0.01% 1945
2019
Q1
$529K Sell
13,905
-409
-3% -$15.6K ﹤0.01% 3348
2018
Q4
$615K Buy
14,314
+4,432
+45% +$190K ﹤0.01% 3288
2018
Q3
$485K Buy
9,882
+1,218
+14% +$59.8K ﹤0.01% 3504
2018
Q2
$278K Buy
8,664
+121
+1% +$3.88K ﹤0.01% 3699
2018
Q1
$266K Sell
8,543
-127,519
-94% -$3.97M ﹤0.01% 3621
2017
Q4
$6.21M Sell
136,062
-61,640
-31% -$2.81M ﹤0.01% 2104
2017
Q3
$7.65M Buy
197,702
+21,277
+12% +$823K ﹤0.01% 1915
2017
Q2
$8.42M Buy
176,425
+23,700
+16% +$1.13M ﹤0.01% 1812
2017
Q1
$6.96M Sell
152,725
-50,838
-25% -$2.32M ﹤0.01% 1898
2016
Q4
$6.58M Buy
203,563
+26,838
+15% +$867K ﹤0.01% 1950
2016
Q3
$6.05M Buy
176,725
+82,701
+88% +$2.83M ﹤0.01% 1886
2016
Q2
$3.17M Sell
94,024
-43,467
-32% -$1.47M ﹤0.01% 2253
2016
Q1
$7.29M Sell
137,491
-2,052
-1% -$109K ﹤0.01% 1770
2015
Q4
$10.7M Sell
139,543
-17,854
-11% -$1.37M ﹤0.01% 1565
2015
Q3
$6.47M Sell
157,397
-55,650
-26% -$2.29M ﹤0.01% 1822
2015
Q2
$15.1M Buy
213,047
+124,772
+141% +$8.82M ﹤0.01% 1428
2015
Q1
$7.85M Sell
88,275
-34,762
-28% -$3.09M ﹤0.01% 1856
2014
Q4
$10.9M Sell
123,037
-150,210
-55% -$13.3M ﹤0.01% 1637
2014
Q3
$26.5M Sell
273,247
-74,283
-21% -$7.2M 0.01% 1131
2014
Q2
$31.9M Buy
347,530
+20,771
+6% +$1.91M 0.01% 1058
2014
Q1
$22.9M Buy
326,759
+60,554
+23% +$4.24M 0.01% 1215
2013
Q4
$15.3M Sell
266,205
-30,590
-10% -$1.76M ﹤0.01% 1405
2013
Q3
$14.3M Buy
296,795
+29,996
+11% +$1.44M ﹤0.01% 1441
2013
Q2
$7.74M Buy
+266,799
New +$7.74M ﹤0.01% 1697